VEGFA and age-related macular degeneration: While the risk factors of macular hemorrhage have been repeatedly suggested to include (at least in AMD) systemic hypertension, antiplatelet and anticoagulant intake and possibly the anti-VEGF therapy itself [3], the prognostic factors of visual improvement after surgical therapy have been described only in a few publications [4,8,9].